XASE
BESS
Nov 06, Last price
3.03USD
1D
14.77%
1Q
5.21%
Jan 2017
1,415.00%
Name
Bitech Technologies Corp
Chart & performance
P/E
—
P/S
—
EPS
Vol. 1Y
145.90%
Shs. 5Y
-92.16%
Rev. 5Y
152.39%
Div Yld LY
—
Div Yld TTM
—
Revenues
3m
Net income
210k
P
CFO
394k
+105.80%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Black Titan Corporation was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. The company offers human capital management solutions and is also focused on strategic expansion into the digital asset and blockchain sectors.
Key people
Benjamin Tran
Chairman of the Board, Chief Executive Officer · since 2024
Benjamin Tran
Chairman of the Board, Chief Executive Officer · since 2022
Chief Financial Officer, Director · since 2022
Sid Sung
Chief Innovation Officer · since 2024
Cole Johnson
President, Director · since 2024
Montgomery Bannerman
Independent Director · since 2024
Van Potter
Independent Director · since 2024
James Stock
Independent Director · since 2024
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑07 | 2024‑12 | 2024‑07 | 2023‑12 | 2023‑07 | 2022‑12 | 2022‑07 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||||
Revenues | |||||||||||||
Cost of revenue | |||||||||||||
Unusual Expense (Income) | |||||||||||||
NOPBT | |||||||||||||
NOPBT Margin | |||||||||||||
Operating Taxes | |||||||||||||
Tax Rate | |||||||||||||
NOPAT | |||||||||||||
Net income | |||||||||||||
Dividends | |||||||||||||
Dividend yield | |||||||||||||
Proceeds from repurchase of equity | |||||||||||||
BB yield | |||||||||||||
| Debt | |||||||||||||
Debt current | |||||||||||||
Long-term debt | |||||||||||||
Deferred revenue | |||||||||||||
Other long-term liabilities | |||||||||||||
Net debt | |||||||||||||
| Cash flow | |||||||||||||
Cash from operating activities | |||||||||||||
CAPEX | |||||||||||||
Cash from investing activities | |||||||||||||
Cash from financing activities | |||||||||||||
FCF | |||||||||||||
| Balance | |||||||||||||
Cash | |||||||||||||
Long term investments | |||||||||||||
Excess cash | |||||||||||||
Stockholders' equity | |||||||||||||
Invested Capital | |||||||||||||
ROIC | |||||||||||||
ROCE | |||||||||||||
| EV | |||||||||||||
Common stock shares outstanding | |||||||||||||
Price | |||||||||||||
Market cap | |||||||||||||
EV | |||||||||||||
EBITDA | |||||||||||||
EV/EBITDA | |||||||||||||
Interest | |||||||||||||
Interest/NOPBT | |||||||||||||